cancerrop产品代理

产品分类 > 科研试剂 > cancerrop产品代理

cancerrop产品代理

在 21 世纪的“后基因组时代”,生命科学的主要关注点是如何正确利用基因序列中包含的信息,为人类健康和福祉做出贡献。 MGMED 开发并商业化了分子诊断技术,以诊断发生在人类生命各个阶段的遗传疾病。 MGMED 专门根据从韩国基因组计划中获得的基因生产微阵列。 例如,BAC芯片微阵列可以快速准确地确定染色体的数量和结构异常。
此外,MGMED 致力于开发用于诊断工具的试剂,例如宫颈癌 PCR 试剂盒、
性传播感染和其他疾病。 以诚信的企业精神,孜孜不倦的研究,
价格: 0.00

Leader of Innovative Molecular Diagnostics

In the 21st century ‘post-genome era’, major concern of life sciences is how to correctly use information   contained in gene sequences in order to contribute to human health and   welfare. MGMED has developed and commercialized molecular diagnostic   techniques to diagnose genetic diseases occurring at all stages of human   life. MGMED has exclusively produced microarray based on the genes obtained   from the Korean Genome Project. For instance, BAC chip microarray can quickly   and accurately determine numerical and structural abnormalities of   chromosomes.

In addition, MGMED makes our effort to develop reagents for   diagnostic tools such as PCR kits for cervical cancer,

   

sexually transmitted infections and other diseases. With


endless efforts in research with honest enterprise sprit,

   

MGMED will become a leading company in molecular diagnostics.